NO810009L - Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks og anvendelse derav - Google Patents

Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks og anvendelse derav

Info

Publication number
NO810009L
NO810009L NO810009A NO810009A NO810009L NO 810009 L NO810009 L NO 810009L NO 810009 A NO810009 A NO 810009A NO 810009 A NO810009 A NO 810009A NO 810009 L NO810009 L NO 810009L
Authority
NO
Norway
Prior art keywords
protrombine
concentrated
complex
procedure
preparation
Prior art date
Application number
NO810009A
Other languages
English (en)
Other versions
NO155477C (no
NO155477B (no
Inventor
Maryse Chanas
Jacques Liautaud
Jean Pla
Edwbard Shanbrom
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of NO810009L publication Critical patent/NO810009L/no
Publication of NO155477B publication Critical patent/NO155477B/no
Publication of NO155477C publication Critical patent/NO155477C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO81810009A 1979-05-04 1981-01-02 Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks. NO155477C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7911272A FR2472390A1 (fr) 1979-05-04 1979-05-04 Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
PCT/FR1980/000069 WO1980002426A1 (fr) 1979-05-04 1980-05-05 Concentres de complexe prothrombinique, preparation et application

Publications (3)

Publication Number Publication Date
NO810009L true NO810009L (no) 1981-01-02
NO155477B NO155477B (no) 1986-12-29
NO155477C NO155477C (no) 1987-04-08

Family

ID=9225039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO81810009A NO155477C (no) 1979-05-04 1981-01-02 Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks.

Country Status (18)

Country Link
US (1) US4465623A (no)
JP (1) JPH0424360B2 (no)
AR (1) AR227021A1 (no)
AT (1) ATA903980A (no)
BE (1) BE883096A (no)
CA (1) CA1157375A (no)
CH (1) CH654329A5 (no)
DE (1) DE3043409C3 (no)
DK (1) DK157169C (no)
ES (1) ES491042A0 (no)
FR (1) FR2472390A1 (no)
GB (1) GB2061287B (no)
IT (1) IT1131109B (no)
MX (1) MX5960E (no)
NL (1) NL8020152A (no)
NO (1) NO155477C (no)
SE (1) SE452250C (no)
WO (1) WO1980002426A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044343B1 (en) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4663164A (en) * 1980-01-28 1987-05-05 Baxter Travenol Laboratories, Inc. Aqueous compositions for treating blood clotting factor inhibitors
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
DE3727610A1 (de) 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US6541275B1 (en) * 1988-02-03 2003-04-01 Dade Behring Inc. Immunoassay for F1.2 prothrombin fragment
JPH0219400A (ja) * 1988-07-07 1990-01-23 Green Cross Corp:The トロンビンまたはプロトロンビンの製造方法
WO1994022471A1 (en) * 1993-04-05 1994-10-13 The Green Cross Corporation Liquid antithrombin iii preparation and method of stabilizing the same
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
USD843660S1 (en) 2017-11-27 2019-03-19 Mary Kay Inc. Cosmetic compact
USD850006S1 (en) 2017-11-27 2019-05-28 Mary Kay Inc. Cosmetic compact
USD863685S1 (en) 2017-11-27 2019-10-15 Mary Kay Inc. Cosmetic compact

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
JPS5314604B2 (no) * 1972-12-20 1978-05-18
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"

Also Published As

Publication number Publication date
IT8021723A0 (it) 1980-05-02
DE3043409T1 (de) 1982-02-18
AR227021A1 (es) 1982-09-15
JPH0424360B2 (no) 1992-04-24
ES8100763A1 (es) 1980-12-01
MX5960E (es) 1984-09-06
DK1281A (da) 1981-01-02
GB2061287B (en) 1983-09-14
SE8009157L (sv) 1980-12-29
CA1157375A (fr) 1983-11-22
BE883096A (fr) 1980-11-03
NO155477C (no) 1987-04-08
IT1131109B (it) 1986-06-18
FR2472390B1 (no) 1983-07-08
SE452250B (sv) 1987-11-23
ES491042A0 (es) 1980-12-01
NO155477B (no) 1986-12-29
JPS56500569A (no) 1981-04-30
DK157169B (da) 1989-11-20
ATA903980A (de) 1982-05-15
SE452250C (sv) 1998-04-06
US4465623A (en) 1984-08-14
CH654329A5 (fr) 1986-02-14
WO1980002426A1 (fr) 1980-11-13
DE3043409C3 (de) 1993-12-23
GB2061287A (en) 1981-05-13
FR2472390A1 (fr) 1981-07-03
DE3043409C2 (no) 1993-12-23
NL8020152A (nl) 1981-02-27
DK157169C (da) 1990-04-23

Similar Documents

Publication Publication Date Title
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO801600L (no) Fremgangsmaate for fremstilling av et bindemiddel for betong og moertler.
NO811759L (no) Fremgangsmaate for fremstiling av en roerformig gjenstand og anordning hertil
NO800830L (no) Fremgangsmaate ved fremstilling av glycinamidderivater
NO802167L (no) Vaffel og fremgangsmaate ved fremstilling av samme
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
DK3880A (da) Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse
NO793440L (no) Eske og fremgangsmaate ved fremstilling av denne
NO792309L (no) Fremgangsmaate til fremstilling av et prosjektil og prosjektil fremstilt ifoelge fremgangsmaaten
NO810009L (no) Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks og anvendelse derav
NO780366L (no) Immunoundertrykkende midler og fremgangsmaate ved fremstilling av disse
PT66076B (en) Positions process for the preparation of herbicide compounds and com
NO150879C (no) Fremgangsmaate for fremstilling av d-camforat av l-carnitinamid og d-camforat av d-carnitinamid
NO801112L (no) Fremgangsmaate for fremstilling av et stabilt saarbehandlingspreparat
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
NO824114L (no) Utgangsmateriale for fremstilling av 5(6)-thiobenzimidazolderivater og fremgangsmaate ved fremstilling derav
NO834461L (no) Fremgangsmaate ved fremstilling av l-carnitin og utgangsmaterialer anvendt ved fremgangsmaaten
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
NO800094L (no) Fremgangsmaate ved utlegning av stroe og innretning for utfoerelse av fremgangsmaaten
NO803159L (no) Fremgangsmaate ved fremstilling av silisium og ferrosilisium
NO802834L (no) Fremgangsmaate ved fremstilling av 2-amino-3-benzoyl-fenylacetamider
DE2966181D1 (en) Derivatives of n-trifluoroacetyl-n-phosphonomethylglycinates and the herbicidal use thereof
NO783479L (no) Fremgangsmaate ved fremstilling av alkyltiosulfater og alkylidentiosulfater
NO803394L (no) Fremgangsmaate for fremstilling av en spuntvegg og en vegg fremstilt ved fremgangsmaaten
AR223703A1 (es) Un procedimiento de preparacion de un trihalometil-carbonato alcalino y cicloalquil-derivado y dicho compuesto